Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Kwang Dong Pharmaceutical Revenue

Kwang Dong Pharmaceutical had revenue of 439.82B KRW in the quarter ending June 30, 2026, with 3.42% growth. This brings the company's total for the last twelve months to 1.71T, up 5.50% year-over-year. In the year 2025, Kwang Dong Pharmaceutical had annual revenue of 1.66T with 1.15% growth. That makes Kwang Dong Pharmaceutical the 6,632nd largest company in the world by revenue and 287th in South Korea.

• Revenue (ttm): 1.71T
• Revenue Growth: +5.50%
• P/S Ratio: 0.19
• Revenue / Employee: 1.70B
• Employees: 1,004
• Market Cap: 323.07B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Food 621.37B 36.9%
• MRO 588.22B 34.9%
• Medicines 456.64B 27.1%
• Other 17.76B 1.1%

By Geography

Chart

• Korea 1.64T 97.1%
• Asia 34.11B 2.0%
• Europe 13.91B 0.8%

Fiscal year ended Dec 31, 2025 See the full Kwang Dong Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.66T	18.79B	1.15%
Dec 31, 2024	1.64T	126.26B	8.34%
Dec 31, 2023	1.51T	82.91B	5.79%
Dec 31, 2022	1.43T	93.36B	6.98%
Dec 31, 2021	1.34T	94.41B	7.59%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error